BCL2 and breast cancer: Several reports described the regulation of Bcl-2 by miR-148a and identified it as one of its target proteins in colorectal cancer (Zhang et al., 2011), pancreatic cancer (Zhang et al., 2014) and breast cancer (Li et al., 2017).